A drug currently used to treat HIV has also been found to dramatically reduce the risk of infection, significantly more than the primary option available for pre-exposure prophylaxis or PrEP. In a ...

A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%. The corresponding study was published in The New England Journal of Medicine. PrEP ...

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, ...

This is a preview. Log in through your library . Abstract Hepatitis C virus (HCV) infection was frequent in human immunodeficiency virus (HIV) patients in Yunnan province. We studied the epidemic ...

HIV Positive Person Precautions: HIV/AIDS can spread not only through sexual relations but also through sharing infected blood, injections, and personal items. HIV Positive Person Precautions: HIV is ...

A woman in the U.S. has died from severe neurological symptoms that were caused by an abnormal protein — which she was unknowingly injected with nearly 50 years earlier. Having shown no neurological ...

As with other drugs, Zilbrysq (zilucoplan) can cause side effects, such as injection site reaction and upper respiratory tract infection. If these side effects become difficult to tolerate, talk with ...

Zoliflodacin, which will be marketed under the name Nuzolvence, is the first new drug to uniquely target gonorrhea infections in decades, and the first developed as part of a public-private ...